Lievens Y - Search Results

1

Estimating the number of fractions by tumour site for European countries in 2012 and 2025: An ESTRO-HERO analysis.

Borras JM, Grau C, Corral J, Wong K, Barton MB, Ferlay J, Bray F, Lievens Y. Borras JM, et al. Among authors: lievens y. Radiother Oncol. 2018 Feb;126(2):198-204. doi: 10.1016/j.radonc.2017.11.009. Epub 2017 Nov 29. Radiother Oncol. 2018. PMID: 29198408

2

Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system?

Lievens Y, Van den Bogaert W, Rijnders A, Kutcher G, Kesteloot K. Lievens Y, et al. Radiother Oncol. 2000 Sep;56(3):289-95. doi: 10.1016/s0167-8140(00)00214-0. Radiother Oncol. 2000. PMID: 10974377

3

Differences in palliative radiotherapy for bone metastases within Western European countries.

Lievens Y, Kesteloot K, Rijnders A, Kutcher G, Van den Bogaert W. Lievens Y, et al. Radiother Oncol. 2000 Sep;56(3):297-303. doi: 10.1016/s0167-8140(00)00215-2. Radiother Oncol. 2000. PMID: 10974378

4

Dose-intensified accelerated vindesine-ifosfamide-cisplatin (VIP) chemotherapy followed by high-dose accelerated hyperfractionated radiotherapy in patients with pathologically proven stage IIIB non-small cell lung cancer: a feasibility study.

De Ruysscher D, Lievens Y, Van den Brande P, Nackaerts K, Vansteenkiste J. De Ruysscher D, et al. Among authors: lievens y. Radiother Oncol. 2002 Jul;64(1):33-6. doi: 10.1016/s0167-8140(02)00144-5. Radiother Oncol. 2002. PMID: 12208572

5

CHART in lung cancer: economic evaluation and incentives for implementation.

Lievens Y, Kesteloot K, Van den Bogaert W. Lievens Y, et al. Radiother Oncol. 2005 May;75(2):171-8. doi: 10.1016/j.radonc.2005.03.011. Radiother Oncol. 2005. PMID: 15878631

6

Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1.

Slotman BJ, Cottier B, Bentzen SM, Heeren G, Lievens Y, van den Bogaert W. Slotman BJ, et al. Among authors: lievens y. Radiother Oncol. 2005 Jun;75(3):349-54. doi: 10.1016/j.radonc.2004.12.005. Epub 2004 Dec 23. Radiother Oncol. 2005. PMID: 15893832

7

Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project.

Bentzen SM, Heeren G, Cottier B, Slotman B, Glimelius B, Lievens Y, van den Bogaert W. Bentzen SM, et al. Among authors: lievens y. Radiother Oncol. 2005 Jun;75(3):355-65. doi: 10.1016/j.radonc.2004.12.007. Epub 2005 Mar 16. Radiother Oncol. 2005. PMID: 16086915

8

Simulating demand for innovative radiotherapies: an illustrative model based on carbon ion and proton radiotherapy.

Pommier P, Lievens Y, Feschet F, Borras JM, Baron MH, Shtiliyanova A, Pijls-Johannesma M. Pommier P, et al. Among authors: lievens y. Radiother Oncol. 2010 Aug;96(2):243-9. doi: 10.1016/j.radonc.2010.04.010. Epub 2010 May 7. Radiother Oncol. 2010. PMID: 20452693

9

The cost of radiotherapy in a decade of technology evolution.

Van de Werf E, Verstraete J, Lievens Y. Van de Werf E, et al. Among authors: lievens y. Radiother Oncol. 2012 Jan;102(1):148-53. doi: 10.1016/j.radonc.2011.07.033. Epub 2011 Aug 26. Radiother Oncol. 2012. PMID: 21872955

10

Health economics in radiation oncology: introducing the ESTRO HERO project.

Lievens Y, Grau C. Lievens Y, et al. Radiother Oncol. 2012 Apr;103(1):109-12. doi: 10.1016/j.radonc.2011.12.026. Epub 2012 Feb 8. Radiother Oncol. 2012. PMID: 22325993 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters